Literature DB >> 26359454

Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.

Xiupeng Zhang1, Xinmiao Yu2, Guiyang Jiang1, Yuan Miao1, Liang Wang1, Yong Zhang1, Yang Liu1, Chuifeng Fan1, Xuyong Lin1, Qianze Dong1, Qiang Han1, Huanyu Zhao1, Yong Han1, Xu Han1, Xuezhu Rong1, Shuting Ding1, Endi Wang3, Enhua Wang4.   

Abstract

Transmembrane protein 88 (TMEM88) is a transmembrane protein that plays a crucial role in regulating human stem cell differentiation and embryonic development. However, its expression and clinicopathologic significance in human neoplasms is unclear. In this study, the expression and subcellular localizations of TMEM88 were assessed in 214 cases of non-small cell lung cancer (NSCLC). Notably, TMEM88 was highly expressed in the cytosol of ∼60% NSCLC specimens examined. Higher expression of cytosolic TMEM88 in NSCLC correlated significantly with poor differentiation, high TNM stage, lymph node metastasis, and inferior survival. In NSCLC cells displaying membrane-localized TMEM88, we observed an inhibition of canonical Wnt signaling due to interactions of TMEM88 with the Wnt pathway factor Dishevelled (DVLS). In contrast, NSCLC cells with cytosol-localized TMEM88 lacked effects on Wnt signaling. Cytosolic interactions of TMEM88 and DVLS increased the expression of phosphorylated, active forms of p38, GSK3β (Thr390), and Snail, thereby reducing the expression of the tight junction-associated proteins ZO-1 and occludin, effects associated with enhanced invasive and metastatic cell characters. Importantly, attenuating the expression of cytosolic TMEM88 reduced metastatic prowess in xenograft models. Overall, our findings show how mislocalization of TMEM88 to the cytosol in NSCLC cells ablates its Wnt pathway regulatory properties, thereby promoting invasion and metastasis by activating the p38-GSK3β-Snail signaling pathway. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26359454     DOI: 10.1158/0008-5472.CAN-14-3828

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management.

Authors:  Mohammad Aslam Khan; Kunwar Somesh Vikramdeo; Sarabjeet Kour Sudan; Seema Singh; Annelise Wilhite; Santanu Dasgupta; Rodney Paul Rocconi; Ajay Pratap Singh
Journal:  Semin Cancer Biol       Date:  2021-08-18       Impact factor: 15.707

2.  TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells.

Authors:  Tao Xu; Lin-Xin Pan; Yun-Xuan Ge; Peng Li; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

3.  Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.

Authors:  Maria de Leon; Horacio Cardenas; Edyta Vieth; Robert Emerson; Matthew Segar; Yunlong Liu; Kenneth Nephew; Daniela Matei
Journal:  Gynecol Oncol       Date:  2016-06-30       Impact factor: 5.482

4.  Synergistic effect of targeting dishevelled-3 and the epidermal growth factor receptor-tyrosine kinase inhibitor on mesothelioma cells in vitro.

Authors:  Gaku Moriyama; Maya Tanigawa; Kosuke Sakai; Yusuke Hirata; Satoshi Kikuchi; Yuriko Saito; Hiroyuki Kyoyama; Kuniko Matsuda; Masahiro Seike; Akihiko Gemma; Kazutsugu Uematsu
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

5.  Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway.

Authors:  Xiupeng Zhang; Guiyang Jiang; Mingfang Sun; Haijing Zhou; Yuan Miao; Mengyuan Liang; Enhua Wang; Yong Zhang
Journal:  Oncotarget       Date:  2017-02-21

6.  Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.

Authors:  Xiupeng Zhang; Yang Liu; Chuifeng Fan; Liang Wang; Ailin Li; Haijing Zhou; Lin Cai; Yuan Miao; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Oncotarget       Date:  2017-08-24

Review 7.  miR-708-5p: a microRNA with emerging roles in cancer.

Authors:  Nicholas J Monteleone; Carol S Lutz
Journal:  Oncotarget       Date:  2017-08-01

8.  TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.

Authors:  Xilin Zhang; Ying He; Yan Jiang; Ying Bao; Qiuqiang Chen; Dong Xie; Huanming Yu; Xiang Wang
Journal:  Oncol Rep       Date:  2021-06-29       Impact factor: 3.906

9.  Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer.

Authors:  Rongna Ma; Nannan Feng; Xiao Yu; Hongyan Lin; Xiaohong Zhang; Oumin Shi; Huan Zhang; Shuo Zhang; Lei Li; Min Zheng; Ming Gao; Herbert Yu; Biyun Qian
Journal:  Cancer Biol Med       Date:  2017-11       Impact factor: 4.248

10.  The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer.

Authors:  Xiaoying Zheng; Qianze Dong; Xiupeng Zhang; Qiang Han; Xu Han; Yong Han; Jingjing Wu; Xuezhu Rong; Enhua Wang
Journal:  Oncotarget       Date:  2017-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.